ORBIMED ADVISORS LLC

Q4 2024 13F Holdings

  • Location
    new york, NY
  • Num holdings

    119

  • Value ($000)

    $4,861,410

  • Date Filed
    02/14/2025
  • Form type
    13F-HR
  • CIK
    0001055951
  • All SEC filings
  • Note
    Holdings aggregated across “other managers” listed in original SEC filing, see here for detailed holdings broken out by other managers
Compare Q4 2024 to
Select Quarter
Issuer Name
Class
CUSIP
VALUE
%
Shares
Principal
Option Type
EWTX
EWTX

EDGEWISE THERAPEUTICS INC

COM
28036F105
$401.08M
8 %

15,021,721

---

SINOVAC BIOTECH LTD

SHS
P8696W104
$334.00M
7 %

2,718,735

BSX
BSX

BOSTON SCIENTIFIC CORP

COM
101137107
$282.28M
6 %

3,160,300

LLY
LLY

ELI LILLY & CO

COM
532457108
$260.63M
5 %

337,600

ISRG
ISRG

INTUITIVE SURGICAL INC

COM NEW
46120E602
$209.67M
4 %

401,700

ELVN
ELVN

ENLIVEN THERAPEUTICS INC

COM
29337E102
$179.09M
4 %

7,959,538

NBIX
NBIX

NEUROCRINE BIOSCIENCES INC

COM
64125C109
$128.05M
3 %

938,120

SYK
SYK

STRYKER CORPORATION

COM
863667101
$124.00M
3 %

344,400

SRPT
SRPT

SAREPTA THERAPEUTICS INC

COM
803607100
$117.14M
2 %

963,400

ARGX
ARGX

ARGENX SE

SPONSORED ADR
04016X101
$116.67M
2 %

189,700

Rows Per Page
10
  • 10
  • 50
  • 100
1 - 10 of 119